Return
Release time:
2020-08-14
Return
■ Jinhua Pharmaceutical Company Tang Wanxiu
My husband and I are from Sichuan. Both families have been farming for generations. It doesn't matter. There is no background. It is difficult to find an ideal job in our hometown. When we "naked marriage", I was at a low point in my life. My work unit was on the verge of bankruptcy and I was facing unemployment at any time. Shortly after marriage, , 2000, , , , , my husband came to work alone with 2,000 yuan borrowed from his classmates. At the beginning of 7
to the peak interview, the interviewer is now the chairman of the group company Jiang Xiaomeng, when he was also the general manager of the pharmaceutical company. Jiang is always very kind and approachable. He let me work in a pharmaceutical company in January. 8 After reporting to the group on March 1 , he also drove me to the pharmaceutical company in his car, which flattered me.
Director Zhou Lin of the pharmaceutical company's office took me to the computer room and introduced me to my colleagues. At that time, there were two colleagues in the computer room, Shi Huifen and Ye Fan. They were very friendly to me. Shi Huifen patiently explained to me the workflow such as purchase, sale and storage like a big sister. I cherish this hard-won job very much. I work very hard every day, humbly ask them for advice and study, and work hard to learn professional and technical knowledge in my spare time. Everyone gets along very well.
Computer Room is responsible for the management and maintenance of information systems in various business departments of pharmaceutical companies, computer and network installation system software, wiring, wiring, maintenance and other work. As long as the business department makes a phone call, we will immediately solve various computer-related problems for them. When we first went to work, we still used the NetWare Dos FoxPro old system platform. later, I also used FoxPro to develop the salesman assessment module. In particular, when bidding for drugs in the hospital, colleagues such as Cheng Fa Hong and Hu Xuechun of the hospital department worked overtime to make bidding materials. I provided Excel technical services at any time and forged a profound revolutionary friendship with them.
As the old system can no longer handle the increasing amount of business information, 2004 7 April, the pharmaceutical company began to upgrade the system. In the next few months, as a member of the upgrade team, I was responsible for the preparation and import of basic data and staff training. During the preliminary investigation, I put forward a proposal to the software manufacturer to increase the automatic early warning function of the system based on my experience when I attended the narcotic drug management training in Beijing in August , 2004 , , , and combined with the actual situation of the pharmaceutical company, which was supported by the leaders. After the module was put on line, I mastered the secondary development technology of this function through learning, and independently wrote more than 10 automatic early warning functions such as "commodity information exceeding the upper inventory limit", "commodity information exceeding the lower inventory limit", "commodity information entering and selling upside down and shifting" and "commodity information arriving in the past two days", which were praised by the leaders. I also participated in the production process of hardware bidding and financial software interface. Through this rare system upgrade practice, I have initially mastered the knowledge of Oracle database management, PB programming language, proxy server and firewall, etc. I also summarized the software, hardware and financial interface involved in the whole upgrade process and saved them as my own knowledge base.
During my peak work, I not only got a good platform for learning and exercise, but also when I encountered difficulties in life, the leaders would enthusiastically help as much as possible, which deeply moved us. After work, through the tourism activities organized by the company, I experienced the beautiful scenery of Jiangnan. Slowly, I fell in love with the city of Jinhua.
but in 2005 , my husband left peak angrily and went to Tianjin due to some interpersonal reasons, so I had to follow. It took me a while to find out that the unit was a private enterprise, and the conditions and atmosphere could not be compared with the peak. I began to miss my former colleagues and the mountains and rivers of Zhejiang.
Coincidentally, at the end of last year, I participated in another interview with Jinhua Pharmaceutical Company. General Manager Wu Weisheng decided to let me return to work in the computer room. So, I returned to the embrace of the peak with a heart of gratitude.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page